Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes

Zhang, ZQ; Chen, X; Lu, PH; Zhang, JH; Xu, YP; He, WT; Li, MN; Zhang, SJ; Jia, J; Shao, SY; Xie, JH; Yang, Y; Yu, XF

Yu, XF (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Endocrinol,Dept Internal Med, 1095 Jiefang Ave, Wuhan 430030, Hubei Province, Peoples R China.

CARDIOVASCULAR DIABETOLOGY, 2017; 16 ( ):

Abstract

Background: Incretin-based agents, including dipeptidyl peptidase-4 inhibitors (DPP-4Is) and glucagon-like peptide- 1 agonists (GLP-1As), work via GLP......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索